Skip to main content
SpringerLink
Log in

Serum Uric Acid to Creatinine Ratio in Patients with Chronic Obstructive Pulmonary Disease

  • COPD
  • Published:
Lung Aims and scope Submit manuscript

Abstract

Serum uric acid (UA), the final product of purine degradation, has been shown to be increased in the hypoxic state. We assessed whether the presence of higher values of serum UA and serum UA to creatinine ratio is associated with clinical or functional characteristics in patients with chronic obstructive pulmonary disease (COPD). Fifty-nine consecutive stable patients with COPD, without comorbid conditions, were included. Clinical and functional characteristics were compared between patients with levels below and above the median values of serum UA and serum UA to creatinine ratio. Patients with serum UA levels above the median value differed significantly from the group with levels below this value only in FVC (p = 0.04), and serum UA did not correlate significantly with the parameters analyzed. Patients with the serum UA to creatinine ratio above the median value had lower FVC (63 ± 18 vs. 73 ± 15 percentage of predicted, p = 0.028), lower FEV1 (43 ± 19 vs. 55 ± 18 percentage of predicted, p = 0.019), and a higher level of dyspnea (MRC scale, 1.5 ± 1.1 vs. 0.8 ± 1.0, p = 0.011). The serum UA to creatinine ratio correlated with FVC (r = −0.27), with FEV1 (r = −0.31), and with dyspnea (r = 0.29). In view of these results, we consider that the serum UA to creatinine ratio warrants evaluation as an additional parameter for predicting outcome in COPD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anker SD, Doehner W, Rauchhaus M, et al. (2003) Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 107:1991–1997

    Article  PubMed  Google Scholar 

  2. Braghiroli A, Sacco C, Erbetta M, et al. (1993) Overnight urinary acid/creatinine ratio for detection of sleep hypoxemia: validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure. Am Rev Respir Dis 148:173–178

    PubMed  CAS  Google Scholar 

  3. Celli B, MacNee W (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23:932–946

    Article  PubMed  CAS  Google Scholar 

  4. Collaborative Group on Intracellular Monitoring (1988) Intracellular monitoring of experimental respiratory failure. Am Rev Respir Dis 138:484–487

    Google Scholar 

  5. De Torres JP, Cordoba-Lanus E, Lopez-Aguilar C, et al. (2006) C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 27:902–907

    PubMed  Google Scholar 

  6. Elsayed NM, Nakashima JM, Poslethwait EM (1993) Measurement of uric acid as a marker of oxygen tension in the lung. Arch Biochem Biophys 302:228–232

    Article  PubMed  CAS  Google Scholar 

  7. Gosker HR, Bast A, Haenen GR, et al. (2005) Altered antioxidant status in peripheral skeletal muscle of patients with COPD. Respir Med 99:118–125

    Article  PubMed  Google Scholar 

  8. Hasday JD, Grum CM (1987) Nocturnal increase of urinary uric acid/creatinine ratio: a biochemical correlate of sleep-associated hypoxemia. Am Rev Respir Dis 135:534–538

    PubMed  CAS  Google Scholar 

  9. Kojima S, Sakamoto T, Ishihara M, et al. (2005) Prognostic usefulness of serum uric acid after acute myocardial infarction. The Japanese Acute Coronary Syndrome Study. Am J Cardiol 96:489–495

    CAS  Google Scholar 

  10. Lewis JG, Gardner JE (1960) The relation of serum uric acid to haemoglobin level in patients with cardiac and respiratory disease. J Clin Pathol 13:502–505

    PubMed  CAS  Google Scholar 

  11. Lopez IH (2003) Serum uric acid levels among patients with chronic obstructive pulmonary disease [abstract]. Chest 124:168S

    Google Scholar 

  12. Mahler DA, Harver A (1992) A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function n patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 145:467–470

    PubMed  CAS  Google Scholar 

  13. Marangella M (2005) Uric acid elimination in the urine. Pathophysiological implications. Contrib Nephrol 147:132–148

    PubMed  CAS  Google Scholar 

  14. Mateos Anton F, Garcia Puig J, Gomez Fernandez P, Ramos Hernandez T, Lopez Jimenez M (1989) Degradation of purine nucleotides in patients with chronic airflow obstruction [in Spanish]. Med Clin (Barc) 92:328–330

    CAS  Google Scholar 

  15. McKenon JL, Saunders NA, Murree-Allen K, et al. (1990) Urinary uric acid to creatinine ratio, serum erythropoietin, and blood 2,3-disphosphoglycerate in patients with obstructive sleep apnea. Am Rev Respir Dis 142:8–13

    Google Scholar 

  16. Nagaya N, Uematsu M, Satoh T, et al. (1999) Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension. Am J Respir Crit Care Med 160:487–492

    PubMed  CAS  Google Scholar 

  17. Oya H, Nagaya N, Satoh T, et al. (2000) Haemodynamic correlates and prognostic singificance of acid uric in adult patients with Eisenmeneger syndrome. Heart 84:53–58

    Article  PubMed  CAS  Google Scholar 

  18. Roca J, Sanchis J, Agusti-Vidal A, et al. (1985) Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 22:217–224

    Google Scholar 

  19. Ruggiero C, Cherubini A, Ble A, et al. (2006) Uric acid and inflammatory markers. Eur Heart J 27:1174–1181

    Article  PubMed  CAS  Google Scholar 

  20. Saito H, Nishimura M, Shibuya E, et al. (2002) Tissue hypoxia in sleep apnea syndrome assessed by uric acid and adenosine. Chest 122:1686–1694

    Article  PubMed  CAS  Google Scholar 

  21. Sato N, Kurashima K, Ubukata M, et al. (2003) Prognostic significance of serum uric acid in patients with chronic obstructive pulmonary disease receiving home oxygen therapy [in Japanese; abstract in English]. 41:74–80

  22. Shimizu Y, Nagaya N, Satoh T, et al. (2002) Serum acid uric level increases in proportion to the severity of pulmonary thromboembolism. Circ J 66:571–575

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Pneumology, Hospital General Universitario, E-03203, Elche, Alicante, Spain

    Eduardo Garcia-Pachon, Isabel Padilla-Navas & Conrado Shum

Authors
  1. Eduardo Garcia-Pachon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Isabel Padilla-Navas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Conrado Shum
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eduardo Garcia-Pachon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garcia-Pachon, E., Padilla-Navas, I. & Shum, C. Serum Uric Acid to Creatinine Ratio in Patients with Chronic Obstructive Pulmonary Disease. Lung 185, 21–24 (2007). https://doi.org/10.1007/s00408-006-0076-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-006-0076-2

Keywords

Search

Navigation